(Q40949361)

25 September 2017

1 reference

title

Treatment of sepsis and septic shock: a review (English)

1 reference

25 September 2017

0 references

1 reference

Wiessner WH

1

1 reference

25 September 2017

Casey LC

series ordinal

2

1 reference

25 September 2017

Zbilut JP

series ordinal

3

1 reference

25 September 2017

language of work or name

1 reference

1 September 1995

1 reference

25 September 2017

1 reference

25 September 2017

volume

24

1 reference

25 September 2017

issue

5

1 reference

25 September 2017

page(s)

380-92; quiz 392-3

1 reference

Modern approaches to the therapy of septic shock

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Septic shock. Evaluation of a life-threatening condition

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

The cardiovascular pathophysiology of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Therapy for overwhelming sepsis--clues for treating disease and not just the symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

The last round against bacterial infections?

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Evaluation of Definitions for Sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

The pharmacotherapy of septic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Sepsis and coagulation. An important link

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Sepsis, the sepsis syndrome, multi-organ failure: a plea for comparable definitions

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Parenteral nutrition in septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Monoclonal antibodies and the treatment of gram-negative bacteremia and shock

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Intensive care medicine--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Effect of acidified enteral feedings on gastric colonization in the critically ill patient

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Nosocomial Pneumonia in Intubated Patients Given Sucralfate as Compared with Antacids or Histamine Type 2 Blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Reducing sepsis in severe combined acute renal and respiratory failure by selective decontamination of the digestive tract.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Nutrient modulation of inflammatory and immune function

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Selective gut decontamination reduces nosocomial infections and length of stay but not mortality or organ failure in surgical intensive care unit patients

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Does selective decontamination of the gastrointestinal tract prevent multiple organ failure? An experimental study

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Ventilatory support in the management of septic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Optimal oxygen delivery in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Fluid loading in septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

To transfuse or not to transfuse--that is the question!

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Cardiovascular and metabolic response to red blood cell transfusion in critically ill volume-resuscitated nonsurgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Septic shock: a goal-directed therapy using volume loading, dobutamine and/or norepinephrine

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Dobutamine administration in septic shock: addition to a standard protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Adrenaline in treatment of septic shock: effects on haemodynamics and oxygen transport

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Experience with phenylephrine as a component of the pharmacologic support of septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine-resistant septic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Oxygen transport in cardiogenic and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Use of vasoactive drugs to support oxygen transport in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Oxygen consumption in sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Energy expenditures of mechanically ventilated nonsurgical patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Systemic inflammatory response syndrome, sepsis, and nutritional support

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Immunonutrition and enteral hyperalimentation of critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Management of gram-negative septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Effect of hypothermia on the coagulation cascade

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Clinical trials of immunotherapy for sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Cytokine serum level during severe sepsis in human IL-6 as a marker of severity

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Interleukin-6 administration has no acute hemodynamic or hematologic effect in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Cost-effectiveness of HA-1A monoclonal antibody for gram-negative sepsis. Economic assessment of a new therapeutic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Ibuprofen in acute-care therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Prospective, controlled, randomized trial of naloxone infusion in early hyperdynamic septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Septic shock: treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Septic shock and multiple organ failure: treatment with haemofiltration?

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Excitement over immunomodulation inundates clinical research meetings

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Nitric oxide: first in a new class of neurotransmitters

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Nitrogen oxide levels in patients after trauma and during sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

An inhibitor of nitric oxide production, NGnitro-L-arginine-methyl ester, improves survival in anaphylactic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Pentoxifylline in septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

Beneficial cardiopulmonary effects of pentoxifylline in experimental sepsis are lost once septic shock is established

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2805%2980059-7

7 January 2021

10.1016/S0147-9563(05)80059-7

Identifiers

DOI

1 reference

25 September 2017

1 reference